Brown Advisory Inc. Acquires 95,249 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brown Advisory Inc. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,746,131 shares of the medical equipment provider’s stock after acquiring an additional 95,249 shares during the period. Intuitive Surgical comprises about 1.2% of Brown Advisory Inc.’s investment portfolio, making the stock its 18th largest holding. Brown Advisory Inc. owned about 0.49% of Intuitive Surgical worth $911,411,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Hurley Capital LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. Finally, BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the sale, the chief financial officer now directly owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,313 shares of company stock worth $17,229,143 in the last ninety days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $529.42 on Friday. The stock has a market capitalization of $189.75 billion, a P/E ratio of 82.59, a PEG ratio of 5.85 and a beta of 1.55. The stock’s fifty day moving average is $504.32 and its 200 day moving average is $533.96. Intuitive Surgical, Inc. has a 52 week low of $379.67 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the previous year, the company earned $1.50 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. Royal Bank of Canada reduced their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Jefferies Financial Group raised their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Truist Financial reduced their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.